Patent · US Active

siRNA targeting superoxide dismutase 1 (SOD1)

US7632938B2 · kind B2 · utility

54Cited by
15References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 29, 2007
Grant dateDec 15, 2009
Priority date
Expiry dateOct 29, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/11
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for SOD1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.